Gender and the use of hormonal contraception in women are not associated with cerebral cortical 5-HT 2A receptor binding

Neuroscience

Volumn 163, Issue 2, 2009, Pages 640-645

  Frokjaer, V G ^a   Erritzoe, D ^a   Madsen, J ^a   Paulson, O B ^b   Knudsen, G M ^a  

^a Mental Health Services CPH   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

5 HT; altanserin; estrogen; hormones; PET; sex

Indexed keywords

ALTANSERIN; CONTRACEPTIVE AGENT; SEROTONIN 2A RECEPTOR;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; HORMONAL CONTRACEPTION; HUMAN; IMAGE ANALYSIS; LIMBIC SYSTEM; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NEUROSIS; POSITRON EMISSION TOMOGRAPHY; PREMENOPAUSE; PRIORITY JOURNAL; RECEPTOR BINDING; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; CEREBRAL CORTEX; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; KETANSERIN; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERSONALITY; PERSONALITY ASSESSMENT; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT2A; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 69249209743     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.06.052     Document Type: Article

References (53)

1. Adams K.H., Pinborg L.H., Svarer C., Hasselbalch S.G., Holm S., Haugbol S., Madsen K., Frokjaer V., Martiny L., Paulson O.B., and Knudsen G.M. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 21 (2004) 1105-1113
2. Arango V., Underwood M.D., Gubbi A.V., and Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688 (1995) 121-133
3. Arnold A.P., Xu J., Grisham W., Chen X., Kim Y.H., and Itoh Y. Minireview: sex chromosomes and brain sexual differentiation. Endocrinology 145 (2004) 1057-1062
4. Bethea C.L., Lu N.Z., Gundlah C., and Streicher J.M. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23 (2002) 41-100
5. Bethea C.L., Mirkes S.J., Shively C.A., and Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol Psychiatry 47 (2000) 562-576
6. 11C]DASB. Am J Psychiatry 164 (2007) 1858-1865
7. Biver F., Lotstra F., Monclus M., Wikler D., Damhaut P., Mendlewicz J., and Goldman S. Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett 204 (1996) 25-28
8. Cahill L. Why sex matters for neuroscience. Nat Rev Neurosci 7 (2006) 477-484
9. Cosgrove K.P., Mazure C.M., and Staley J.K. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62 (2007) 847-855
10. Erritzoe D., Frokjaer V.G., Haugbol S., Marner L., Svarer C., Holst K., Baaré W.F., Rasmussen P.M., Madsen J., Paulson O.B., and Knudsen G.M. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 15 (2009) 23-30
11. Freeman E.W., Sammel M.D., Lin H., and Nelson D.B. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 63 (2006) 375-382
12. Frokjaer V.G., Mortensen E.L., Nielsen F.A., Haugbol S., Pinborg L.H., Adams K.H., Svarer C., Hasselbalch S.G., Holm S., Paulson O.B., and Knudsen G.M. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biol Psychiatry 63 (2008) 569-576
13. Gundlah C., Lu N.Z., and Bethea C.L. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology 160 (2002) 271-282
14. Haugbol S., Pinborg L.H., Arfan H.M., Frokjaer V.M., Madsen J., Dyrby T.B., Svarer C., and Knudsen G.M. Reproducibility of 5-HT(2A) receptor measurements and sample size estimations with [(18)F]altanserin PET using a bolus/infusion approach. Eur J Nucl Med Mol Imaging 34 (2007) 910-915
15. Henderson J.A., and Bethea C.L. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 33 (2008) 285-293
16. Jovanovic H., Cerin A., Karlsson P., Lundberg J., Halldin C., and Nordstrom A.L. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 148 (2006) 185-193
17. Jovanovic H., Karlsson P., Cerin A., Halldin C., and Nordström A.L. 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11C] MADAM PET. Psychiatry Res 172 (2009) 31-37
18. Jovanovic H., Lundberg J., Karlsson P., Cerin A., Saijo T., Varrone A., Halldin C., and Nordström A.L. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 39 (2008) 1408-1419
19. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., and Nelson C.B. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J Affect Disord 29 (1993) 85-96
20. Kilpatrick L.A., Zald D.H., Pardo J.V., and Cahill L.F. Sex-related differences in amygdala functional connectivity during resting conditions. Neuroimage 30 (2006) 452-461
21. Kugaya A., Epperson C.N., Zoghbi S., van Dyck C.H., Hou Y., Fujita M., Staley J.K., Garg P.K., Seibyl J.P., and Innis R.B. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 160 (2003) 1522-1524
22. Lewinsohn P.M., Rohde P., Seeley J.R., and Baldwin C.L. Gender differences in suicide attempts from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry 40 (2001) 427-434
23. 18F]setoperone in neuroleptic-naive patients and normal subjects. Am J Psychiatry 156 (1999) 72-78
24. Lu N.Z., and Bethea C.L. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27 (2002) 12-24
25. Lu N.Z., Eshleman A.J., Janowsky A., and Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Mol Psychiatry 8 (2003) 353-360
26. Lundberg J., Borg J., Halldin C., and Farde L. A PET study on regional coexpression of 5-HT(1A) receptors and 5-HTT in the human brain. Psychopharmacology (Berl) 195 (2007) 425-433
27. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., and Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57 (2000) 729-738
28. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., Goulding V., Kennedy J., and Wilson A.A. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 61 (2004) 1271-1279
29. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., and Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry 48 (2000) 854-860
30. Moses-Kolko E.L., Berga S.L., Greer P.J., Smith G., Cidis Meltzer C., and Drevets W.C. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil Steril 80 (2003) 554-559
31. Naughton M., Mulrooney J.B., and Leonard B.E. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 15 (2000) 397-415
32. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 94 (1997) 5308-5313
33. O'Connor K.A., and Roth B.L. Finding new tricks for old drugs: an efficient route for public-sector drug discovery. Nat Rev Drug Discov 4 (2005) 1005-1014
34. Oquendo M.A., and Mann J.J. The biology of impulsivity and suicidality. Psychiatr Clin North Am 23 (2000) 11-27
35. Osterlund M.K., and Hurd Y.L. Acute 17 beta-estradiol treatment downregulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res 55 (1998) 169-172
36. Osterlund M.K., and Hurd Y.L. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol 64 (2001) 251-267
37. Östlund H., Keller E., and Hurd Y.L. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 1007 (2003) 54-63
38. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., and Mann J.J. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954 (2002) 173-182
39. Pearlstein T., Rosen K., and Stone A.B. Mood disorders and menopause. Endocrinol Metab Clin North Am 26 (1997) 279-294
40. Pecins-Thompson M., Brown N.A., and Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res 53 (1998) 120-129
41. Pigott T.A. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 60 (1999) 4-15
42. 18F]altanserin-PET and the bolus/infusion approach. J Cereb Blood Flow Metab 23 (2003) 985-996
43. Riecher-Rössler A., and Häfner H. Schizophrenia and oestrogens-is there an association?. Eur Arch Psychiatry Clin Neurosci 242 (1993) 323-328
44. 123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender. Eur J Nucl Med Mol Imaging 36 (2009) 841-849
45. Sheline Y.I., Mintun M.A., Moerlein S.M., and Snyder A.Z. Greater loss of 5-HT(2A) receptors in midlife than in late life. Am J Psychiatry 159 (2002) 430-435
46. Skovdahl-Hansen H., Mortensen E.L., and Scioetz H.K. Dokumentation for den danske udgave af NEO PI-R og NEO PI-R Kort Version. In: Skovdahl-Hansen H., and Mortensen E. (Eds) (2004), Dansk Psykologisk Forlag, Copenhagen, Denmark
47. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41 (2001) 275-284
48. Staley J.K., Sanacora G., Tamagnan G., Maciejewski P.K., Malison R.T., Berman R.M., Vythilingam M., Kugaya A., Baldwin R.M., Seibyl J.P., Charney D., and Innis R.B. Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry 59 (2006) 40-47
49. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 37 (2003) 357-373
50. Sumner B.E., and Fink G. Testosterone as well as estrogen increases serotonin 2A receptor mRNA and binding site densities in the male rat brain. Brain Res 59 (1998) 205-214
51. Sumner B.E., Grant K.E., Rosie R., Hegele-Hartung C., Fritzemeier K.H., and Fink G. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neurosci Lett 417 (2007) 95-99
52. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbol S., Frokjaer V.G., Holm S., Paulson O.B., and Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 24 (2005) 969-979
53. Takano A., Arakawa R., Hayashi M., Takahashi H., Ito H., and Suhara T. Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry 62 (2007) 588-592